Jan Henrik Klug - JoVE Visualize

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Molecular Pharmacology|November 18, 2022

Differences in Sustained Cellular Effects of MET inhibitors Are Driven by Prolonged Target Engagement and Lysosomal RetentionNina Berges, Jan Henrik Klug, Anna Eicher, et al.

JHEP Reports : Innovation in Hepatology|February 18, 2026

Co-administered internalizing RGD peptide boosts anti-PD-L1 therapy in hepatocellular carcinomaJan Henrik Klug, Blerina Aliraj, Lucia Alcober-Boquet, et al.

Ebiomedicine|June 18, 2024

Tumour-specific activation of a tumour-blood transport improves the diagnostic accuracy of blood tumour markers in miceChristian Schmithals, Bianca Kakoschky, Dominic Denk, et al.

Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Molecular Pharmacology|November 18, 2022

Differences in Sustained Cellular Effects of MET inhibitors Are Driven by Prolonged Target Engagement and Lysosomal RetentionNina Berges, Jan Henrik Klug, Anna Eicher, et al.

JHEP Reports : Innovation in Hepatology|February 18, 2026

Co-administered internalizing RGD peptide boosts anti-PD-L1 therapy in hepatocellular carcinomaJan Henrik Klug, Blerina Aliraj, Lucia Alcober-Boquet, et al.

Ebiomedicine|June 18, 2024

Tumour-specific activation of a tumour-blood transport improves the diagnostic accuracy of blood tumour markers in miceChristian Schmithals, Bianca Kakoschky, Dominic Denk, et al.

Pageof 1